Ocular Imaging for Monitoring of Ocular Tumor Disease
Summary
The purpose of this study is to compare two devices used for optical coherence tomography (OCT). OCT is a noninvasive imaging (scanning) method that uses reflected light to create pictures of the back of the eye, and doctors can use OCT to detect and monitor different types of cancer
Arms & interventions
- Diagnostic TestIntalight Dream OCT
This is a next-generation swept-source device that has a faster imaging speed and higher sensitivity than the previous generation of frequency-domain OCT devices, which serve as the current standard of care devices.
- Diagnostic TestHeidelberg Spectralis OCT
This is the standard of care for optical imaging.
Outcome measures
Primary
Image quality for participants
Evaluated by next-generation swept-source OCT versus standard OCT for imaging of the eye and any relevant ocular tumors.
Time frame: Up to 1 year
Field of view for participants
Evaluated by next-generation swept-source OCT versus standard OCT for imaging of the eye and any relevant ocular tumors.
Time frame: Up to 1 year
Eligibility criteria
Study locations (7)
Memorial Sloan Kettering at Basking Ridge (Consent Only)
Basking Ridge, New Jersey, 07920
Memorial Sloan Kettering Monmouth (Consent only)
Middletown, New Jersey, 07748
Memorial Sloan Kettering Bergen (Consent Only)
Montvale, New Jersey, 07645
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only)
Commack, New York, 11725
Memorial Sloan Kettering Westchester (Consent Only)
Harrison, New York, 10604
Memorial Sloan Kettering Cancer Center (All Protocol Activites)
New York, New York, 10065
Memorial Sloan Kettering Cancer Center @ Nassau (Consent only)
Uniondale, New York, 11553